Spain's major-impact medicine supply problems drop below 0.20% for first time in five years
AEMPS's first-half 2026 report shows notified supply incidents rising overall, while those with the greatest care impact fell to 0.17% of authorised presentations.
The Spanish Agency for Medicines and Medical Devices (AEMPS) has published its supply problems report for the first half of 2026. It shows more notified incidents overall, but fewer with major impact on care. Major-impact problems accounted for 0.17% of authorised presentations, the lowest share in five years and the first time in that period below 0.20%. The figure was 0.24% in the second half of 2025.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Article written by VigiEye from the official source (AEMPS). AI-assisted; check the source before acting.